Active	Status	Sponsor type	Region	Phase	Filter
1 Active 5 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
veldoreotide (DG3173) / Xeris Biopharma
NCT04138342: Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer	Recruiting	1	30	RoW	Quantum dots coated with veldoreotide, Topical cream, Topical approved placebo, Topical placebo gel or cream	Al-Azhar University	Breast Cancer, Skin Cancer, Skin Diseases	06/21	12/22